Skip to main content
OpenTrials

Clinical trial condition

Non-Hodgkin's Lymphoma

Explore clinical trials studying Non-Hodgkin's Lymphoma. Study availability and eligibility vary by location and protocol.

250 public trials 21 recruiting studies
Refine in advanced search Browse all conditions

Non-Hodgkin's Lymphoma trial results

Completed

Allo-hNHL (FluBuCy)

NCT00785330

Conditions
Disease Attributes, Graft vs Host Disease, Hemic and Lymphatic Diseases, +16 more
Locations
  • Universitätsklinikum Heidelberg Heidelberg, Baden-Würtenberg, Germany
  • Universitätsklinikum Marburg Marburg, Hesse, Germany
  • Universitätsklinikum und Poliklinik Homburg, Saarland, Germany
  • University Hospital Goettingen Göttingen, Germany
View Trial Details
Completed

A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)

NCT01059630

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Southern Cancer Center, PC Mobile, Alabama, United States
  • Dr. Donald W. Hill, MD, FACP Casa Grande, Arizona, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Kaiser Permanente - Bellflower Bellflower, California, United States
View all 121 locations
View Trial Details
Completed

A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma

NCT00343564

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +9 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Cornell University Medical Center New York, United States
  • Memorial Sloan-Kettering Caner Center New York, United States
  • Herbert Irving Comprehensive Cancer Center New York, United States
View Trial Details
Completed

Pharmacokinetics and Safety Study of Azacitidine in Cancer Patients With and Without Impaired Renal Function

NCT00652626

Conditions
AML, Blood Protein Disorders, Cardiovascular Diseases, +28 more
Locations
  • Sutter East Bay Hospitals Berkeley, California, United States
  • Palm Springs Research Institute Hialeah, Florida, United States
  • MCG Cancer Center Augusta, Georgia, United States
  • Joliet Oncology-Hematology Associates, Ltd. Joliet, Illinois, United States
View Trial Details
Completed

Ublituximab in Combination With TGR-1202 +/- Ibrutinib or Bendamustine in Patients With B-cell Malignancies

NCT02006485

Conditions
Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +17 more
Locations
  • TG Therapeutics Investigational Trial Site Huntsville, Alabama, United States
  • TG Therapeutics Investigational Trial Site Jonesboro, Arkansas, United States
  • TG Therapeutics Investigational Trial Site Duarte, California, United States
  • TG Therapeutics Investigational Trial Site Atlanta, Georgia, United States
View Trial Details
Completed

Trial of VELCADE and Rituxan as Front-line Tx for Low-grade NHL

NCT00369707

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • University of Miami Sylvester Comprehensive Cancer Center - Miami Miami, Florida, United States
  • Hematology-Oncology Associates of Illinois Chicago, Illinois, United States
  • Northwestern University Chicago, Illinois, United States
  • Fox Chase Cancer Center - Philadelphia Philadelphia, Pennsylvania, United States
View Trial Details
Completed

A Study of Escalating Doses of DCDS0780A in Participants With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma

NCT02453087

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations
  • City of Hope National Medical Center Duarte, California, United States
  • Stanford Cancer Center Stanford, California, United States
  • Medical Center of Aurora; Rocky Mountain Cancer Centers Aurora, Colorado, United States
  • Georgetown University Medical Center Lombardi Cancer Center Washington D.C., District of Columbia, United States
View Trial Details

Related conditions